EU plans for better access to low-cost generics and biosimilars in new pharmaceutical strategy
The EU Commission wants to give Europeans more affordable and more accessible medicines, and then the European pharmaceutical industry needs to be strengthened and the safety of the supply chains needs to be top-notch next time we face a pandemic.
BY LOUISE WENDT JENSEN, TRANSLATED BY NIELSINE NIELSEN
BRUSSELS
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Moderna reveals price of coronavirus vaccine
For subscribers
Irishwoman takes over EMA Executive Director position
For subscribers
.jpg&w=384&q=75)
